Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€3.22
11.06.21
€4.00
11.06.22
-69.57%
14.12.21

Could be worthwhile Investment >10% per year
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€18.77
11.06.21
€23.20
11.06.22
-14.32%
24.06.21

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
buy
Galapagos N.V.

Start price
Target price
Perf. (%)
€65.08
09.06.21
€70.00
09.06.22
-30.73%
13.10.21

Could be worthwhile Investment >10% per year
buy
Invitae Corp

Start price
Target price
Perf. (%)
€25.10
09.06.21
€30.00
09.06.22
-89.88%
10.06.22

Could be worthwhile Investment >10% per year
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€320.85
08.06.21
€330.00
08.06.22
-41.88%
08.06.22

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Top 10 in its market
Well known brand
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€49.93
07.06.21
€55.00
07.06.22
42.14%
08.06.22

Could be worthwhile Investment >10% per year
buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€238.80
07.06.21
€250.00
29.04.22
15.03%
30.04.22

Could be worthwhile Investment >10% per year
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€38.32
07.06.21
€48.00
07.06.22
4.12%
21.06.21

Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Little Investments for future growth
buy
Diasorin SpA

Start price
Target price
Perf. (%)
€142.25
06.06.21
-
06.06.22
-15.04%
07.06.22

Could be worthwhile Investment >10% per year
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€91.61
03.06.21
€115.00
03.06.22
34.21%
04.06.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.22
03.06.21
-
03.06.22
-2.82%
26.02.22

Revenue growth > 30% per year expected
Undervalued
High Investments for future growth
Top Rating
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.30
02.06.21
-
02.06.22
9.09%
20.06.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
M1 Kliniken AG

Start price
Target price
Perf. (%)
€10.35
31.05.21
-
31.05.24
40.10%
11.03.24

Could be worthwhile Investment >10% per year
buy
Haemato AG

Start price
Target price
Perf. (%)
€29.20
31.05.21
-
31.05.24
-36.99%
11.03.24

Could be worthwhile Investment >10% per year
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.74
31.05.21
€15.00
31.05.22
-60.61%
01.06.22

Fair valuation
Strong uniques
Leading role in innovation
Bad rating
buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€2.18
31.05.21
€4.00
31.05.22
4.59%
14.06.21

Could be worthwhile Investment >10% per year
buy
Ziopharm Oncology

Start price
Target price
Perf. (%)
€2.44
31.05.21
€4.00
31.05.22
-2.46%
07.06.21

Could be worthwhile Investment >10% per year
buy
Aravive, Inc.

Start price
Target price
Perf. (%)
€4.16
31.05.21
€7.00
31.05.22
1.44%
14.06.21

Could be worthwhile Investment >10% per year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€7.24
31.05.21
€12.00
31.05.22
0.62%
14.06.21

Could be very worthwhile Investment >20% year
buy
Advicenne

Start price
Target price
Perf. (%)
€8.74
30.05.21
€10.00
30.05.22
-10.98%
31.08.21

Could be worthwhile Investment >10% per year
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€128.00
30.05.21
€96.00
30.05.22
-32.52%
20.12.21

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
Getinge AB B

Start price
Target price
Perf. (%)
€28.89
29.05.21
€35.00
29.05.22
-6.89%
30.05.22

buy
Exact Sciences

Start price
Target price
Perf. (%)
€91.24
29.05.21
€115.00
29.05.22
-44.66%
30.05.22

buy
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€2.86
29.05.21
-
29.05.22
-71.59%
30.05.22

Could be very worthwhile Investment >20% year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€125.18
28.05.21
€200.00
28.05.22
-35.69%
29.01.22

Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Significant cyclical dependencies